About
Rare Diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
106
By Phase
PHASE1: 2PHASE2: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07185113Lead Sponsor
A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects
PHASE1Not yet recruiting
6 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2025
NCT05795465Lead Sponsor
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
PHASE2Recruiting
52 participants
Started: Apr 4, 2023 · Completed: Dec 31, 2026
NCT04728061Lead Sponsor
Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GEn1E-1124
PHASE1Completed
48 participants
Started: Jan 7, 2021 · Completed: Jun 18, 2021
Funding History (1)
D
Dec 21, 2022
Locations (1)
Headquarters
Palo Alto, CA, United States
Map
Loading map...